Kenichi Suda, MD, PhD

377-2 Ohno-Higashi, Osaka-Sayama 589-8511, Japan

Education:
April 2007 – March 2011:
Graduate School of Medical Science, Kyushu University, Japan.
April 1999 – March 2005:
Faculty of Medical Science, Kyushu University, Japan.

Experience:
April 2018 – Present: Associate Professor / Lecturer (Surgery)
Division of Thoracic Surgery, Kindai University Faculty of Medicine, Japan.
January 2018 – March 2018: Assistant Professor (Surgery)
Division of Thoracic Surgery, Kindai University Faculty of Medicine, Japan.
September 2015 – December 2017: Research Associate
Division of Medical Oncology, University of Colorado AMC, USA.
May 2013 – August 2015: Assistant Professor (Surgery)
Division of Thoracic Surgery, Kindai University Faculty of Medicine, Japan.
April 2012 – April 2013: Medical Staff (Surgery)
Department of Surgery and Science, Kyushu University Hospital, Japan.
April 2011 – March 2012: Junior Resident
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Japan.
April 2005 – March 2007: Clinical Trainee Fukuoka City Hospital, Japan.

List of recent publications
1. Suda K, Kim J, Murakami I, et al. Innate genetic evolution of lung cancers and spatial heterogeneity: Analysis of treatment-naive lesions. J Thorac Oncol. 2018.
2. Suda K, Rozeboom L, Furugaki K, et al. Increased EGFR phosphorylation correlates with higher programmed death ligand-1 expression: analysis of TKI- resistant lung cancer cell lines. Biomed Res Int. 2017.
3. Suda K, Rozeboom L, Rivard CJ, et al. Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells. Lung Cancer 2017.
4. Suda K, Bunn PA, Rivard CR, et al. Primary double-strike therapy for cancers to overcome EGFR kinase inhibitor resistance: proposal from the bench. J Thorac Oncol., 2017.